Aminolevulinic acid hydrochloride - Generic Drug Details
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What are the generic drug sources for aminolevulinic acid hydrochloride and what is the scope of patent protection?
Aminolevulinic acid hydrochloride
is the generic ingredient in three branded drugs marketed by Nxdc, Biofrontera, and Dusa, and is included in three NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.Aminolevulinic acid hydrochloride has nine patent family members in four countries.
There are five drug master file entries for aminolevulinic acid hydrochloride. Three suppliers are listed for this compound.
Summary for aminolevulinic acid hydrochloride
International Patents: | 9 |
US Patents: | 4 |
Tradenames: | 3 |
Applicants: | 3 |
NDAs: | 3 |
Drug Master File Entries: | 5 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 141 |
Clinical Trials: | 96 |
Patent Applications: | 5,714 |
Formulation / Manufacturing: | see details |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for aminolevulinic acid hydrochloride |
What excipients (inactive ingredients) are in aminolevulinic acid hydrochloride? | aminolevulinic acid hydrochloride excipients list |
DailyMed Link: | aminolevulinic acid hydrochloride at DailyMed |
Recent Clinical Trials for aminolevulinic acid hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Westfälische Wilhelms-Universität Münster | Phase 1/Phase 2 |
photonamic GmbH & Co. KG | Phase 1/Phase 2 |
Alpheus Medical, Inc. | Phase 1 |
Pharmacology for aminolevulinic acid hydrochloride
Drug Class | Optical Imaging Agent Porphyrin Precursor |
Mechanism of Action | Fluorescence Contrast Activity |
Medical Subject Heading (MeSH) Categories for aminolevulinic acid hydrochloride
US Patents and Regulatory Information for aminolevulinic acid hydrochloride
Expired US Patents for aminolevulinic acid hydrochloride
International Patents for aminolevulinic acid hydrochloride
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 2019123708 | 光線力学療法のための局所用組成物、閉塞性ドレッシング材、それを用いたキット、光線力学療法材料、および光線力学療法のための方法 (TOPICAL COMPOSITION FOR PHOTODYNAMIC THERAPY, OCCLUSIVE DRESSING MATERIAL, KIT USING THE SAME, PHOTODYNAMIC THERAPY MATERIAL, AND METHOD FOR PHOTODYNAMIC THERAPY) | See Plans and Pricing |
Australia | 2021102111 | Methods for photodynamic therapy | See Plans and Pricing |
Australia | 2020103365 | Methods for photodynamic therapy | See Plans and Pricing |
Australia | 2020267186 | Methods for photodynamic therapy | See Plans and Pricing |
Canada | 3029792 | METHODES DE THERAPIE PHOTODYNAMIQUE (METHODS FOR PHOTODYNAMIC THERAPY) | See Plans and Pricing |
World Intellectual Property Organization (WIPO) | 2022078955 | See Plans and Pricing | |
Australia | 2019200152 | Methods for photodynamic therapy | See Plans and Pricing |
>Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:






Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.